T1	Participants 50 87	older sarcopenic obese New Zealanders
T2	Participants 154 166	older adults
T3	Participants 567 757	One hundred eighty-three older adults (age 72.7 +/- 6 years, range 56-93; body mass index 28.2 +/- 4.9, range 16.6-46.0) were recruited from a New Zealand falls prevention intervention trial
T4	Participants 1144 1224	Regression models were adjusted for age, sex, medications, and physical activity
T5	Participants 1234 1259	Femoral neck osteoporosis
T6	Participants 759 1037	Total and appendicular skeletal muscle mass (ASM), percent fat, and bone mineralization were assessed by dual energy X-ray absorptiometry and used to characterize normal lean (NL, n = 51), sarcopenic (SS, n = 18), sarcopenic obese (SO, n = 29), and obese (OO, n = 85) phenotypes
T7	Participants 1310 1348	Femoral neck osteoporosis with low ASM
T8	Participants 1431 1433	SO
T9	Participants 1504 1514	Higher ASM
T10	Participants 1615 1641	low ASM groups (SS and SO)
